Abstract
The advanced Large Language Model ChatGPT4o, developed by OpenAI, can be used in the field of bioinformatics to analyze and understand cross-reactive allergic reactions. This study explores the use of ChatGPT4o to support research on allergens, particularly in the cross-reactivity syndrome between cat and pork. Using a hypothetical clinical case of a child with a confirmed allergy to Fel d 2 (cat albumin) and Sus s 1 (pork albumin), the model guided data collection, protein sequence analysis, and three-dimensional structure visualization. Through the use of bioinformatics tools like SDAP 2.0 and BepiPRED, the epitope regions of the allergenic proteins were predicted, confirming their accessibility to immunoglobulin E (IgE) and probability of cross-reactivity. The results show that regions with high epitope probability exhibit high surface accessibility and predominantly coil and helical structures. The construction of a phylogenetic tree further supported the evolutionary relationships among the studied allergens. ChatGPT4o has demonstrated its usefulness in guiding non-specialist researchers through complex bioinformatics processes, making advanced science accessible and improving analytical and innovation capabilities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
